Product Information

PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Endo USA Inc., priced at $0.2829 per EA under NDC 67253065110. Its NADAC has been published 640 times since Aug 20, 2014.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROPYLTHIOURACIL 50 MG TABLET

Propylthiouracil
$0.2829per EA

Strength

50 mg/1

Manufacturer

Endo USA Inc.

NDC

67253065110

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROPYLTHIOURACIL

Approval Type

New Drug (NDA)

FDA Application

NDA006188

FDA Approved

Before 1982

TE Code

AB

On Market Since

7/28/1947

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 640 times since Aug 20, 2014, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2829 per EA
All-time high$0.7308 (May 13, 2015)
All-time low$0.2149 (May 22, 2024)
52-week high$0.2847
52-week low$0.2646
Median price$0.5222
Average price$0.5058
Largest weekly change-44.1% (May 22, 2024)
Weeks tracked640
Tracking sinceAug 20, 2014

Price History

1W

+5.0%

1M

+5.3%

3M

+4.7%

6M

-0.7%

1Y

-2.4%

3Y

-26.9%

5Y

-40.5%

All

-57.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Endo USA Inc., is $0.2829 per EA (NDC 67253065110), effective Nov 18, 2026.

How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has declined 57.7%. It has been tracked across 640 weekly CMS publications since Aug 20, 2014.

What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?

Since Aug 20, 2014, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2149 (May 22, 2024) to a high of $0.7308 (May 13, 2015), with a median of $0.5222 per EA.

Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPYLTHIOURACIL 50 MG TABLET, is $0.2724 per EA — about 4% below PROPYLTHIOURACIL 50 MG TABLET.

Who manufactures PROPYLTHIOURACIL 50 MG TABLET?

PROPYLTHIOURACIL 50 MG TABLET (NDC 67253065110) is labeled by Endo USA Inc., and CMS classifies it as a generic product.